January 26, 2023
The MMA has developed an FAQ to provide additional details and information on the MMA’s new policy, “Decriminalization of Simple Possession of Illicit Drugs.” The policy, which was adopted by the MMA Board of Trustees on December 12, 2022, was recommended by the MMA Policy Council following months of research and deliberation by a work group.
On January 16, MinnPost published an article about the policy, featuring perspectives from MMA President Will Nicholson, MD, and MMA Illicit Drug Work Group Chair Ryan Kelly, MD. They spoke to the evidence and health equity considerations behind the new policy.
“The science on this topic is pretty clear,” Nicholson said. “Criminalizing addiction and addictive behavior doesn’t get the best outcome for the patient.”
The article goes on to say, “while substance use disorder occurs across all ethnic and racial lines, Nicholson and Kelly both believe that unequal and punitive enforcement of drug possession laws has only expanded gaps that already existed in American society.”
The article reinforces the distinction between decriminalization of drug possession and drug legalization, which would involve state-regulated production and sales of illicit drugs. The MMA policy does not support legalization.
For more information, contact Adrian Uphoff, health policy analyst.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.